Valuation GuiZhou SanLi Pharmaceutical Co.,Ltd

Stocks

End-of-day quote Shanghai S.E. Other stock markets 2026-07-15			5-day change	1st Jan Change
11.64 ^CNY	+1.66%		-9.06%	-0.51%

05-26	Guizhou Sanli Pharmaceutical to Raise Up to 700 Million Yuan in Private Placement	MT
05-25	Guizhou Sanli pharmaceutical to raise funds via private placement	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	8,252	6,483	5,637	7,738	5,205	4,735
Change	-	-21.44%	-13.05%	37.27%	-32.74%	-9.02%
Enterprise Value (EV) ¹	7,872	6,041	5,212	7,670	5,313	5,084
Change	-	-23.26%	-13.73%	47.17%	-30.74%	-4.3%
P/E	84.4x	42.6x	28x	26.6x	19.4x	106x
PBR	8.4x	6.29x	4.55x	5.24x	3.45x	3.28x
PEG	-	0.8x	0.9x	0.6x	-3.44x	-1.3x
Capitalization / Revenue	13.1x	6.9x	4.69x	4.73x	2.43x	2.78x
EV / Revenue	12.5x	6.43x	4.34x	4.69x	2.48x	2.99x
EV / EBITDA	69.7x	37x	23.7x	25.3x	13.2x	19.6x
EV / EBIT	75.1x	39.8x	25.5x	28.7x	16.2x	27.3x
EV / FCF	-133x	110x	40.8x	-209x	54.4x	-88.4x
FCF Yield	-0.75%	0.91%	2.45%	-0.48%	1.84%	-1.13%
Dividend per Share ²	0.25	-	0.1	0.2	0.34	0.06
Rate of return	1.23%	-	0.73%	1.06%	2.62%	0.51%
EPS ²	0.24	0.37	0.49	0.71	0.67	0.11
Distribution rate	104%	-	20.4%	28.2%	50.7%	54.5%
Net sales ¹	630.2	939	1,201	1,635	2,144	1,703
EBITDA ¹	113	163.1	220.2	303.2	402.3	258.8
EBIT ¹	104.9	151.9	204.6	267.2	328.3	186.1
Net income ¹	93.95	152.3	201.3	292.7	274	46.25
Net Debt ¹	-380.1	-442.2	-425.1	-67.86	107.7	348.7
Reference price ²	20.26	15.78	13.72	18.88	13.00	11.70
Nbr of stocks (in thousands)	407,322	410,862	410,862	409,862	400,382	404,740
Announcement Date	4/28/21	4/21/22	4/14/23	4/26/24	4/22/25	4/26/26

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
GUIZHOU SANLI PHARMACEUTICAL CO.,LTD	-	-	-	-	684M
ELI LILLY AND COMPANY	34.25x	12.25x	25.43x	0.59%	1,028B
JOHNSON & JOHNSON	27.09x	6.22x	16.9x	2.1%	611B
ABBVIE INC.	30.33x	7.27x	14.9x	2.81%	432B
ROCHE HOLDING AG	17.47x	4.34x	10.68x	3.06%	323B
NOVARTIS AG	21.17x	5.44x	13.17x	2.9%	277B
ASTRAZENECA PLC	20.69x	4.37x	12.08x	2.02%	257B
NOVO NORDISK A/S	13.99x	5.26x	10.84x	3.55%	217B
AMGEN INC.	23.3x	6.19x	10.94x	2.84%	192B
GILEAD SCIENCES, INC.	-46.85x	5.61x	31x	2.5%	161B
Average	15.72x	6.33x	16.22x	2.48%	349.9B
Weighted average by Cap.	23.34x	7.66x	17.88x	2.04%